A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies

Inclusion Criteria:

• Participant is willing to comply with the requirements of the study including beingphotographed, following post-treatment care instructions, attending all study visitsand providing a signed written informed consent.

• Males or non-pregnant, non-breastfeeding females, over the age of 18.

• Intent to receive treatment for temporary augmentation in the chin region.

Exclusion Criteria:

• Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA)gel or to gram positive bacterial proteins and/or local anesthetics, e.g., lidocaineor other amide-type anesthetics

• Previous or present multiple allergies or severe allergies, such as manifested byanaphylaxis or angioedema, or family history of these conditions.

• Previous facial surgery (including facial aesthetic surgery and liposuction), belowthe level of the horizontal line from the lower orbital rim.

• Any previous aesthetic procedures or implants.

• Use of concomitant medication that have the potential to prolong bleeding times suchas anticoagulants or inhibitors of platelet aggregation.

• Participation in any other interventional clinical study within 30 days (about 4 anda half weeks) before baseline.

• Women who are pregnant or breast feeding, or women of childbearing potential who arenot practicing adequate contraception or planning to become pregnant during thestudy period.